HIPAA- and GDPR-compliant trusted research environments for AI and federated analytics
Design a TRE that supports HIPAA and GDPR. Enable secure, cross-border research with controlled access to sensitive health data.
Check out the latest thinking from our team — explore our blog, read white papers, watch videos, and more.
Design a TRE that supports HIPAA and GDPR. Enable secure, cross-border research with controlled access to sensitive health data.
Predictive AI depends on clinically rich real-world data. Learn how organizations generate predictive insights for drug development.
Understand how longitudinal RWD helps oncology teams evaluate long-term outcomes, quality of life, and treatment pathways beyond clinical trials.
A multi-country observational study provided insight into treatment practices, care pathways, and pregnancy outcomes in a rare disease.
Most RWE platforms can generate analyses. Few deliver results that can be validated, reused, and applied with confidence.
RWE in oncology must stand up to regulatory, HTA, and access scrutiny—requiring decision‑grade, multimodal, globally relevant data.
Why most medical research data platform strategies fail — based on a recent Frontiers review, and what it takes to scale AI and RWE.
Clinical trial delays often start in study design. Real‑world data and AI help teams reduce amendments, improve recruitment, and avoid 6-12 months of delay.
AI is making data accessed through the EHDS usable—turning fragmented access into secure, scalable workflows.